Recap: Protalix BioTherapeutics Q4 Earnings

  Protalix BioTherapeutics (AMEX:PLX) reported its Q4 earnings results on Thursday, March 31, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

 

Protalix BioTherapeutics (AMEX:PLX) reported its Q4 earnings results on Thursday, March 31, 2022 at 06:50 AM.

Here’s what investors need to know about the announcement.

Earnings

Protalix BioTherapeutics missed estimated earnings by 27.27%, reporting an EPS of $-0.14 versus an estimate of $-0.11.

Revenue was down $10.95 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 4.35% drop in the share price the next day.

Here’s a look at Protalix BioTherapeutics’s past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.11 -0.08 -0.17 -0.08
EPS Actual -0.09 -0.25 -0.14 0.03
Revenue Estimate 7.79M 8.30M 10.95M 11.99M
Revenue Actual 12.05M 6.43M 11.32M 19.50M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts